BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28552691)

  • 21. Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures.
    Liu J; Lu H; Lu YF; Lei X; Cui JY; Ellis E; Strom SC; Klaassen CD
    Toxicol Sci; 2014 Oct; 141(2):538-46. PubMed ID: 25055961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of a Drug-Induced, Bile Acid-Dependent Hepatotoxicity Model Using HepaRG Cells.
    Susukida T; Sekine S; Nozaki M; Tokizono M; Oizumi K; Horie T; Ito K
    J Pharm Sci; 2016 Apr; 105(4):1550-60. PubMed ID: 26952880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro bile acid-dependent hepatocyte toxicity assay system using human induced pluripotent stem cell-derived hepatocytes: Current status and disadvantages to overcome.
    Sakai Y; Iwao T; Susukida T; Nukaga T; Takemura A; Sekine S; Ito K; Matsunaga T
    Drug Metab Pharmacokinet; 2019 Aug; 34(4):264-271. PubMed ID: 31285099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular Accumulation and Toxic Effects of Bile Acids in Cyclosporine A-Treated HepaRG Hepatocytes.
    Sharanek A; Burban A; Humbert L; Bachour-El Azzi P; Felix-Gomes N; Rainteau D; Guillouzo A
    Toxicol Sci; 2015 Oct; 147(2):573-87. PubMed ID: 26198044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive and Preferential Cellular Accumulation of Hydrophobic Bile Acids Induced by Cholestatic Drugs Is Associated with Inhibition of Their Amidation and Sulfation.
    Sharanek A; Burban A; Humbert L; Guguen-Guillouzo C; Rainteau D; Guillouzo A
    Drug Metab Dispos; 2017 Dec; 45(12):1292-1303. PubMed ID: 28928138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transport.
    Wolf KK; Vora S; Webster LO; Generaux GT; Polli JW; Brouwer KL
    Toxicol In Vitro; 2010 Feb; 24(1):297-309. PubMed ID: 19706322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vesicle- and Hepatocyte-Based Assays for Identification of Drug Candidates Inhibiting BSEP Function.
    Van Brantegem P; Deferm N; Qi B; De Vocht T; Annaert P
    Methods Mol Biol; 2019; 1981():55-73. PubMed ID: 31016647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of high basolateral bile salt efflux to the lack of hepatotoxicity in rat in response to drugs inducing cholestasis in human.
    Jemnitz K; Veres Z; Vereczkey L
    Toxicol Sci; 2010 May; 115(1):80-8. PubMed ID: 20147439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of membrane cholesterol on BSEP/Bsep activity: species specificity studies for substrates and inhibitors.
    Kis E; Ioja E; Nagy T; Szente L; Herédi-Szabó K; Krajcsi P
    Drug Metab Dispos; 2009 Sep; 37(9):1878-86. PubMed ID: 19520776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
    Funk C; Ponelle C; Scheuermann G; Pantze M
    Mol Pharmacol; 2001 Mar; 59(3):627-35. PubMed ID: 11179459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment.
    Cheng Y; Freeden C; Zhang Y; Abraham P; Shen H; Wescott D; Humphreys WG; Gan J; Lai Y
    Biopharm Drug Dispos; 2016 Jul; 37(5):276-86. PubMed ID: 27059119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.
    Mita S; Suzuki H; Akita H; Hayashi H; Onuki R; Hofmann AF; Sugiyama Y
    Drug Metab Dispos; 2006 Sep; 34(9):1575-81. PubMed ID: 16760228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
    Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
    Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic Activation of Cholestatic Drug-Induced Bile Acid-Dependent Toxicity in Human Sandwich-Cultured Hepatocytes.
    Ogimura E; Tokizono M; Sekine S; Nakagawa T; Bando K; Ito K
    J Pharm Sci; 2017 Sep; 106(9):2509-2514. PubMed ID: 28465153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic-Induced Elevations of Plasma Bile Acids in Rats Independent of Bsep Inhibition.
    Li Y; Hafey MJ; Duong H; Evers R; Cheon K; Holder DJ; Galijatovic-Idrizbegovic A; Sistare FD; Glaab WE
    Toxicol Sci; 2017 May; 157(1):30-40. PubMed ID: 28108666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus-mediated human aquaporin-1 expression in hepatocytes improves lipopolysaccharide-induced cholestasis.
    Marrone J; Danielli M; Gaspari CI; Marinelli RA
    IUBMB Life; 2017 Dec; 69(12):978-984. PubMed ID: 29087027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A possible role of chenodeoxycholic acid and glycine-conjugated bile acids in fibrotic steatohepatitis in a dietary rat model.
    Jia X; Suzuki Y; Naito H; Yetti H; Kitamori K; Hayashi Y; Kaneko R; Nomura M; Yamori Y; Zaitsu K; Kato M; Ishii A; Nakajima T
    Dig Dis Sci; 2014 Jul; 59(7):1490-501. PubMed ID: 24448653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor.
    Deng R; Yang D; Yang J; Yan B
    J Pharmacol Exp Ther; 2006 Apr; 317(1):317-25. PubMed ID: 16371446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive Value of Cellular Accumulation of Hydrophobic Bile Acids As a Marker of Cholestatic Drug Potential.
    Burban A; Sharanek A; Humbert L; Eguether T; Guguen-Guillouzo C; Rainteau D; Guillouzo A
    Toxicol Sci; 2019 Apr; 168(2):474-485. PubMed ID: 30629237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.